This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Anthem (ANTM) Inks Deal to Acquire Beacon Health Options
by Zacks Equity Research
Anthem (ANTM) enters into an agreement to buy Beacon Health Options for enhancing health outcomes of patients.
Ensign Group (ENSG) on Buyout Spree to Enrich Portfolio
by Zacks Equity Research
Ensign Group (ENSG) purchases the assets of Preceptor Health Care and the real estate and operations of Golden Palms Rehabilitation and Retirement.
U.S. Service Sector Expands at a Brisk Pace: Top 5 Winners
by Tirthankar Chakraborty
The U.S. service sector grows faster in May defying slowdown in economic growth and rising trade tensions.
3 Reasons Why Growth Investors Shouldn't Overlook HCA (HCA)
by Zacks Equity Research
HCA (HCA) possesses solid growth attributes, which could help it handily outperform the market.
Universal Health's Segmental Strength Aids, High Costs Hurt
by Zacks Equity Research
Solid segmental contributions bode well for Universal Health's (UHS) growth. However, elevated expenses are a lingering concern.
Why Is HCA (HCA) Down 1.8% Since Last Earnings Report?
by Zacks Equity Research
HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Add WellCare Health (WCG) to Your Portfolio?
by Zacks Equity Research
Riding high on a solid revenue base and inorganic growth profile, WellCare Health (WCG) holds high potential to reap benefits for investors.
Why Adding HCA Healthcare to Your Portfolio Makes Sense
by Zacks Equity Research
Riding high on rising revenues and inorganic growth story, HCA Healthcare (HCA) looks promising enough to garner benefits for investors.
Here is Why Growth Investors Should Buy HCA (HCA) Now
by Zacks Equity Research
HCA (HCA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Looking for Value? Why It Might Be Time to Try HCA Healthcare (HCA)
by Zacks Equity Research
HCA Healthcare (HCA) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Hospital Industry Outlook: Demography, Consolidation Act As Tailwinds
by Sapna Bagaria
Hospital industry to gain from demographical changes and growing consolidation, partially offset by high labor cost.
Solid US Labor Market Puts Focus on 3 Sector ETFs & Stocks
by Sanghamitra Saha
The U.S. labor market has been in great shape defying slowdown worries. Unemployment rate fell to a fresh 49-year low in April. Play this optimism with these sector ETFs and stocks.
The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins
3 Reasons Growth Investors Will Love HCA (HCA)
by Zacks Equity Research
HCA (HCA) possesses solid growth attributes, which could help it handily outperform the market.
Top Stock Reports for Pfizer, Intel & HCA Healthcare
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), Intel (INTC) and HCA Healthcare (HCA).
HCA Healthcare's (HCA) Q1 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter earnings gain traction from higher revenues and better admissions.
HCA Healthcare (HCA) Q1 Earnings and Revenue Beat Estimates
by Zacks Equity Research
HCA Healthcare (HCA) first-quarter earnings gain from solid revenues.
What's in Store for HCA Healthcare's (HCA) Q1 Earnings?
by Zacks Equity Research
HCA Healthcare (HCA) is likely to gain from higher admissions. However, escalating expenses might weigh down its margins.
Earnings Preview: HCA Holdings (HCA) Q1 Earnings Expected to Decline
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Modest Moves in the Big Indexes During the Week, but Still Plenty of Action
by David Borun
The broad markets ended slightly higher during a holiday-shortened week, but two high profile IPOs were the big story
Medicare-for-All, Mueller Report Spell Danger: 5 Utility Picks
by Swarup Gupta
Superior dividend yields and steady revenues make utilities good choices in tough times.
HCA Healthcare's Organic & Inorganic Strategies Drive Growth
by Zacks Equity Research
A number of acquisitions, network expansion, technological investment and strong balance sheet drive growth at HCA Healthcare (HCA).
HCA Healthcare to Buy Large Stake in Galen College of Nursing
by Zacks Equity Research
HCA Healthcare (HCA) to purchase the majority interest in Galen College of Nursing for boosting access to nursing education.
Is HCA Healthcare (HCA) a Worthy Pick for Value Investors?
by Zacks Equity Research
HCA Healthcare (HCA) stock may be a good choice for value-oriented investors right now from multiple angles.
Stock Market News For Mar 7, 2019
by Zacks Equity Research
Benchmarks ended in the red on Wednesday after a slew of weak economic reports weighed on the markets.